$ChemoCent_老虎社区_美港股上老虎

马麻虎狐
2021-10-09

$ChemoCentryx(CCXI)$不用怕明天增发，要融资也是发非流通的以前多万股，不会对股价造成太大影响（可以参考XENE）况且这是为数不多的FDA完全批准了的公司。

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":821802186,"tweetId":"821802186","gmtCreate":1633713310978,"gmtModify":1633713310978,"author":{"id":3547602626419671,"authorId":3547602626419671,"authorIdStr":"3547602626419671","name":"马麻虎狐","avatar":"https://static.tigerbbs.com/d423063b9ad9596395e2452f24527984","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":3,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p><a target=\"_blank\" href=\"https://laohu8.com/S/CCXI\">$ChemoCentryx(CCXI)$</a>不用怕明天增发，要融资也是发非流通的以前多万股，不会对股价造成太大影响（可以参考XENE）况且这是为数不多的FDA完全批准了的公司。 </p></body></html>","htmlText":"<html><head></head><body><p><a target=\"_blank\" href=\"https://laohu8.com/S/CCXI\">$ChemoCentryx(CCXI)$</a>不用怕明天增发，要融资也是发非流通的以前多万股，不会对股价造成太大影响（可以参考XENE）况且这是为数不多的FDA完全批准了的公司。 </p></body></html>","text":"$ChemoCentryx(CCXI)$不用怕明天增发，要融资也是发非流通的以前多万股，不会对股价造成太大影响（可以参考XENE）况且这是为数不多的FDA完全批准了的公司。","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":2,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/821802186","repostId":0,"isVote":1,"tweetType":1,"viewCount":1724,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["CCXI"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":140,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}

评论（2）

热议股票